Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Palisade Bio Inc PALI

Healthcare Biotechnology

Palisade Bio, Inc. is a biopharmaceutical company focused on developing novel therapeutics for serious chronic gastrointestinal diseases. It is engaged in advancing a PALI-2108 for the treatment of IBD, including UC and CD and are researching PALI-1908. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract. UC primarily affects the colon and the rectum. CD... see more

Add To Watchlist

Recent & Breaking News (NDAQ:PALI)

Neuralstem Reports First Quarter 2015 Financial Results And Provides Business and Clinical Update

PR Newswire May 8, 2015

Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer

PR Newswire May 6, 2015

Neuralstem Reports Fiscal 2014 Fourth Quarter Financial And Year-End Business Results

PR Newswire March 16, 2015

Neuralstem Announces Topline Results Of Phase II ALS Trial

PR Newswire March 12, 2015

Neuralstem To Present At Barclays Global Healthcare Conference 2015

PR Newswire March 4, 2015

Neuralstem to Present at BIO CEO & Investor Conference 2015

PR Newswire February 3, 2015

Neuralstem To Present At Biotech Showcase 2015

PR Newswire January 6, 2015

Neuralstem NSI-189 Phase Ib Major Depression Disorder Neurogenic Biomarker Data Presented At The CNS Summit

PR Newswire November 17, 2014

Neuralstem Announces Publication Of Long Term Cell Survival From Phase I NSI-566 ALS Study In The Journal "Annals Of Clinical And Translational Neurology"

PR Newswire November 10, 2014

Neuralstem Reports Third Quarter Financial Results And Provides Business And Clinical Update

PR Newswire November 7, 2014

Neuralstem Alzheimer's Disease Animal Data Presented At The Congress Of Neurological Surgeons Annual Meeting

PR Newswire October 23, 2014

First Patient Treated In Neuralstem Phase I Spinal Cord Injury Stem Cell Trial Through The UC San Diego Sanford Stem Cell Clinical Center

PR Newswire October 9, 2014

Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data

PR Newswire September 22, 2014

Neuralstem President And CEO To Present At The 2014 Rodman & Renshaw Annual Global Investment Conference

PR Newswire September 5, 2014

Leading Health Care Stock for Small-Cap Stars is Chromadex Corp (CDXC) for August 28

Equities.com August 28, 2014

Leading Health Care Stock for Small-Cap Stars is Galectin Therapeutics Inc. (GALT) for August 27

Equities.com August 27, 2014

Leading Small-Cap Stars Health Care Stock for August 27 Morning Session is Galena Biopharma Inc. (GALE)

Equities.com August 27, 2014

Rodman & Renshaw 2014 Annual Global Investment Conference to be held in New York from September 8 to 10, 2014

Business Wire August 11, 2014

Leading Health Care Stock for Small-Cap Stars is Raptor Pharmaceutical Corp. (RPTP) for August 8

Equities.com August 8, 2014

Neuralstem Reports Second Quarter Financial Results And Provides Business And Clinical Update

PR Newswire August 8, 2014